alexa Evaluation of bioequivalency and toxicological effects of three sources of arachidonic acid (ARA) in domestic piglets.
Nutrition

Nutrition

Journal of Food: Microbiology, Safety & Hygiene

Author(s): Tyburczy C, Brenna ME, DeMari JA, Kothapalli KS, Blank BS, , Tyburczy C, Brenna ME, DeMari JA, Kothapalli KS, Blank BS,

Abstract Share this page

Abstract Arachidonic acid (ARA) and docosahexaenoic acid (DHA) are routinely added to infant formula to support growth and development. We evaluated the bioequivalence and safety of three ARA-rich oils for potential use in infant formula using the neonatal pig model. The primary outcome for bioequivalence was brain accretion of ARA and DHA. Days 3-22 of age, domestic pigs were fed one of three formulas, each containing ARA at ∼0.64\% and DHA at ∼0.34\% total fatty acids (FA). Control diet ARA was provided by ARASCO and all diets had DHA from DHASCO (Martek Biosciences Corp., Columbia, MD). The experimental diets a1 and a2 provided ARA from Refined Arachidonic acid-rich Oil (RAO; Cargill, Inc., Wuhan, China) and SUNTGA40S (Nissui, Nippon Suisan Kaisha, Ltd., Tokyo, Japan), respectively. Formula intake and growth were similar across all diets, and ARA was bioequivalent across treatments in the brain, retina, heart, liver and day 21 RBC. DHA levels in the brain, retina and heart were unaffected by diet. Liver sections, clinical chemistry, and hematological parameters were normal. We conclude that RAO and SUNTGA40S, when added to formula to supply ∼0.64\% ARA are safe and nutritionally bioequivalent to ARASCO in domestic piglets. Copyright © 2011 Elsevier Ltd. All rights reserved.
This article was published in Food Chem Toxicol and referenced in Journal of Food: Microbiology, Safety & Hygiene

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords